semaglutide discontinuation study denmark 2025 september Long-term comparative effectiveness of once-weekly versus alternative treatments in a real-world US adult population with type 2 diabetes: a randomized pragmatic clinical trial High Rates of Semaglutide Discontinuation

HEY YALL WELCOME BACK TO THE CHANNEL

Yes GLP3 is the informal name for retatrutide, a triple agonist of GLP-1, GIP, and glucagon receptors.

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatments

#GLP1 #Noom #ObesityTreatment #DigitalHealth #WeightLoss #Semaglutide #HealthTech #CompoundedDrugs #PharmaInnovation #BehavioralHealth

Initial Consultation to confirm eligibility $150 Request AppointmentIncludes - Medication is $400/Month - Includes Monthly visits with provider - One Semaglutide Injection/WeekDedicated To Patients Seeking Weight Loss Management